DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
INSULIN, PROTAMINE ZINC
4
Protein
Approved
Unknown
Unknown
Unknown
Unknown
INSULIN, PROTAMINE ZINC
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BENZOIC ACID
4
Small molecule
Approved
Unknown
Unknown
Urinary Tract Infections
Unknown
BENZOIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
8SKN0B0MIM
Molecule Type:
Small molecule
Molecular Formula:
C7H6O2
Molecular Weight:
122.12
AlogP:
1.38
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
TWINRIX
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TWINRIX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
4
Combination
Approved
IMMUNE SYSTEM
ORAL
Unknown
Unknown
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GUAIFENESIN; HYDROCODONE BITARTRATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
GUAIFENESIN; HYDROCODONE BITARTRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SITOSTEROLS
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
SITOSTEROLS
×
Maximum Phase:
4
First Approval:
None
UNII:
G7V636VTDY
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AM
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
AM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORTHALIDONE; METOPROLOL TARTRATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORTHALIDONE; METOPROLOL TARTRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POLICOSANOL
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Unknown
POLICOSANOL
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GEMEPROST
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
GEMEPROST
×
Maximum Phase:
4
First Approval:
None
UNII:
45KZB1FOLS
Molecule Type:
Small molecule
Molecular Formula:
C23H38O5
Molecular Weight:
394.55
AlogP:
3.98
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
12.0
Source:
DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HEXAMIDINE
4
Small molecule
Approved
Unknown
Unknown
Eye Infections; Nasal Obstruction
Unknown
HEXAMIDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
3483C2H13H
Molecule Type:
Small molecule
Molecular Formula:
C20H26N4O2
Molecular Weight:
354.45
AlogP:
3.27
PSA:
118.2
HBD:
4.0
HBA:
#RotB:
11.0
Source:
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FERROUS GLYCINE SULFATE
4
Small molecule
Approved
Unknown
Unknown
Anemia
Unknown
FERROUS GLYCINE SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
56PS9HY5XI
Molecule Type:
Small molecule
Molecular Formula:
C4H10FeN2O8S
Molecular Weight:
302.04
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RAVULIZUMAB-CWVZ
4
Antibody
Approved
Unknown
INJECTION
Unknown
Unknown
RAVULIZUMAB-CWVZ
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIATRIZOATE MEGLUMINE
4
Small molecule
Approved
OTHER
INJECTION; URETERAL; URETHRAL
Ileus
Diagnostic agent
DIATRIZOATE MEGLUMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
3X9MR4N98U
Molecule Type:
Small molecule
Molecular Formula:
C18H26I3N3O9
Molecular Weight:
809.13
AlogP:
3.12
PSA:
95.5
HBD:
3.0
HBA:
#RotB:
3.0
Source:
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEQUITAZINE
4
Small molecule
Approved
Unknown
Unknown
Hypersensitivity
Unknown
MEQUITAZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Y463242LY2
Molecule Type:
Small molecule
Molecular Formula:
C20H22N2S
Molecular Weight:
322.48
AlogP:
4.63
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
2.0
Source:
ATROPINE; PRALIDOXIME CHLORIDE
4
Combination
Approved
OTHER
INTRAMUSCULAR
Unknown
Unknown
ATROPINE; PRALIDOXIME CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL
4
Combination
Approved
OTHER
INTRAVENOUS
Unknown
Unknown
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CELIPROLOL
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Adrenergic receptor alpha-2 antagonist
CELIPROLOL
×
Maximum Phase:
4
First Approval:
None
UNII:
DRB57K47QC
Molecule Type:
Small molecule
Molecular Formula:
C20H33N3O4
Molecular Weight:
379.5
AlogP:
2.89
PSA:
90.9
HBD:
3.0
HBA:
#RotB:
9.0
Source:
ACETIC ACID, GLACIAL; HYDROCORTISONE; NEOMYCIN SULFATE
4
Combination
Approved
OTHER
OTIC
Unknown
Unknown
ACETIC ACID, GLACIAL; HYDROCORTISONE; NEOMYCIN SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALCURONIUM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Muscarinic acetylcholine receptor M2 positive allosteric modulator
ALCURONIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
S8U3J5W06N
Molecule Type:
Small molecule
Molecular Formula:
C44H50N4O2+2
Molecular Weight:
666.91
AlogP:
5.48
PSA:
46.94
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ALBUMIN IODINATED I-125 SERUM
4
Protein
Approved
OTHER
INJECTION
Unknown
Unknown
ALBUMIN IODINATED I-125 SERUM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
4
Combination
Approved
OTHER
ORAL; ORAL SUSPENSION
Unknown
Unknown
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)
4
Combination
Approved
OTHER
VAGINAL
Unknown
Unknown
TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BENZIODARONE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Calmodulin inhibitor
BENZIODARONE
×
Maximum Phase:
4
First Approval:
None
UNII:
75CL65GTYR
Molecule Type:
Small molecule
Molecular Formula:
C17H12I2O3
Molecular Weight:
518.09
AlogP:
5.14
PSA:
50.44
HBD:
1.0
HBA:
#RotB:
3.0
Source:
TROPISETRON
4
Small molecule
Approved
Unknown
Unknown
Pain; Nausea
Serotonin 3 (5-HT3) receptor antagonist
TROPISETRON
×
Maximum Phase:
4
First Approval:
None
UNII:
6I819NIK1W
Molecule Type:
Small molecule
Molecular Formula:
C17H20N2O2
Molecular Weight:
284.36
AlogP:
2.95
PSA:
45.33
HBD:
1.0
HBA:
#RotB:
2.0
Source:
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FENTICONAZOLE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
FENTICONAZOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
QG05NRB077
Molecule Type:
Small molecule
Molecular Formula:
C24H20Cl2N2OS
Molecular Weight:
455.41
AlogP:
7.3
PSA:
27.05
HBD:
0.0
HBA:
#RotB:
8.0
Source:
CYCLOBARBITAL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CYCLOBARBITAL
×
Maximum Phase:
4
First Approval:
None
UNII:
0M8A98AD9H
Molecule Type:
Small molecule
Molecular Formula:
C12H16N2O3
Molecular Weight:
236.27
AlogP:
1.25
PSA:
75.27
HBD:
2.0
HBA:
#RotB:
2.0
Source:
DOCETAXEL
4
Unknown
Approved
Unknown
INJECTION
Unknown
Unknown
DOCETAXEL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
281
282
283
284
285
286
287
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA